Loading clinical trials...
Loading clinical trials...
Intravitreal Injection Using 33-gauge Versus 30-gauge Needles: Comparison of Patients' Experience
Conditions
Interventions
Varying needle size with intravitreal ranibizumab or aflibercept
Locations
1
United States
Mid Atlantic Retina- Wills Eye Hospital
Philadelphia, Pennsylvania, United States
Start Date
January 27, 2017
Primary Completion Date
April 27, 2017
Completion Date
April 27, 2017
Last Updated
July 25, 2017
NCT07449936
NCT07449923
NCT07228559
NCT05802329
NCT07249216
NCT06781255
Lead Sponsor
Wills Eye
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions